Sue Peschin, MHS

home / authors / sue-peschin-mhs

Articles

The CMS CED Policy Limits Treatment for Early Alzheimer's Disease: What It Is and How It Works

The CMS CED Policy Limits Treatment for Early Alzheimer's Disease: What It Is and How It Works

Sue Peschin, MHS
December 16th 2024

The coverage with evidence development (CED) policy requires enrollment in an active clinical trial for an adult to be eligible for Medicare coverage of treatment for Alzheimer's disease.

eimer Disease are ‘Worth It’ / image credit Sue Peschin, MHS, Alliance for Aging Research

Dear Payers: Drugs for Early Alzheimer's Disease are ‘Worth It’

Sue Peschin, MHS
October 7th 2024

Medicare’s restrictive coverage policies are denying patients with early Alzheimer's disease access to novel treatments. And private payers are following suit.

Latest Updated Articles

What Cause of This Itchy Rash?
Published: April 11th 2014 | Updated: August 21st 2025
What Cause of This Itchy Rash?
nt Improvements in Hidradenitis Suppurativa Observed During Treatment with GLP-1 Receptor Agonists / image credit ©syahrir/stock.adobe.com
Published: August 19th 2025 | Updated: August 21st 2025
Improvements in Hidradenitis Suppurativa Observed During Treatment with GLP-1 Receptor Agonists
Guidance or Guesswork? Navigating 2025–26 Vaccine Recommendations
Published: August 19th 2025 | Updated: August 21st 2025
Shifts in CDC Policy on COVID-19 Vaccination for Children Dilute Protection for the Vulnerable Population, ID Specialist Warns
RDX-002 Hits Primary and Secondary Endpoints for Post-GLP-1 Weight Management / image credit ©missbobbit/stock.adobe.com
Published: August 14th 2025 | Updated: August 21st 2025
RDX-002 Hits Primary and Secondary End Points for Post–GLP-1 Weight Management
Guideline Topline: 2025 AHA/ACC Hypertension / image credit Dan Jones, MD, University of Mississippi Foundation
Published: August 15th 2025 | Updated: August 21st 2025
AHA/ACC Release Revised Hypertension Clinical Practice Guideline to Reduce CVD Risk
Noninvasive Primary Care Screening Identifies Elevated LVEDP in Nearly 40% of High-Risk Patients
Published: August 12th 2025 | Updated: August 21st 2025
Noninvasive Primary Care Screening Identifies Elevated LVEDP in Nearly 40% of High-Risk Patients
© 2025 MJH Life Sciences

All rights reserved.